What the Recent White House Announcement Means for IVFMD Patients
On October 16, President Trump announced a new initiative aimed at expanding access to fertility care in the United States. While this announcement has brought national attention to the importance of fertility treatment, it’s essential to understand what this means for patients at IVFMD.
For the most current updates, we recommend visiting the Prelude Network website.
Key Takeaways from the Announcement
-
Discounted IVF Medications via TrumpRx. A new government-supported platform, TrumpRx.gov, is expected to launch in January 2026. It will offer discounts on three commonly prescribed IVF medications from EMD Serono: Gonal-f®, Ovidrel®, and Cetrotide®.
-
Employer Fertility Benefits. Federal guidance now encourages employers to offer standalone fertility benefits—similar to dental or vision plans. These benefits are optional and not federally mandated or subsidized.
-
FDA Fast-Tracking Fertility Drug Approval. The FDA will prioritize review of Pergoveris, a fertility medication from EMD Serono, to accelerate its availability in the U.S.
What This Means for IVFMD Patients
While these initiatives are encouraging, they are not yet active. Here’s what our patients should know as we prepare for potential changes in 2026:
-
If you’re currently in treatment: Your medication plan will remain the same. Once discounts become available, our team will help you determine if future cycles qualify.
-
If you’re planning IVF: Medication costs may decrease in 2026. We’ll keep you informed as TrumpRx launches and pricing details are finalized.
-
If your employer offers insurance: You may see expanded fertility benefits in the future.
-
For all patients: Lower medication costs and broader coverage could make IVF more accessible for many families. IVFMD will continue to monitor these developments and share updates as they unfold.
Important Notes
-
TrumpRx is not yet live. It is expected to launch in January 2026, but no official date has been confirmed.
-
Discounts apply only to select EMD Serono medications, which may not be used in every treatment plan.
IVFMD is committed to transparency and support as these changes take shape.
For more details, see: Reuters — White House set to announce proposal seeking to make IVF more accessible
Our Advice: Don’t Wait to Start Treatment
In fertility care, time is one of the most valuable resources. If you’re currently facing infertility or struggling to grow your family, it’s important not to delay seeking support. At IVFMD, we’re here to offer compassionate, expert care tailored to your needs—today and in the future.
Whether you're just starting out or exploring new options, our team is ready to walk with you every step of the way. We’ll continue to monitor developments and share updates as more information becomes available.
If you have questions about how this announcement might affect your treatment plan, please don’t hesitate to reach out to your care team.